UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 11, 2008
BioScrip, Inc.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
Delaware
|
|
0-28740
|
|
05-0489664 |
(State or Other Jurisdiction of
|
|
(Commission
|
|
(IRS Employer |
Incorporation)
|
|
File Number)
|
|
Identification No.) |
|
|
|
100 Clearbrook Road, Elmsford, New York
|
|
10523 |
(Address of Principal Executive Offices)
|
|
(Zip Code) |
Registrants telephone number, including area code (914) 460-1600
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12). |
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240-14d-2(b)). |
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)). |
Item 2.01 Entry Into a Material Definitive Agreement.
On August 11, 2008, BioScrip, Inc. (the Company), through its subsidiaries BioScrip Pharmacy
Services, Inc., BioScrip Infusion Services, Inc., BioScrip Pharmacy (NY), Inc., BioScrip PBM
Services, LLC, BioScrip Pharmacy, Inc., Natural Living, Inc., BioScrip Infusion Services, LLC and
Bradhurst Specialty Pharmacy, Inc. (collectively, the Borrowers), entered into a Third Amendment
to the Amended and Restated Loan and Security Agreement (the LSA) among the Borrowers and HFG
Healthco-4 LLC, an affiliate of Healthcare Finance Group, Inc. (HFG), which increased the amount
of the revolving commitment under the LSA from $75,000,000 to $85,000,000. The increase in the
amount of the revolving commitment was necessary in order to fund the Companys increased working
capital requirements primarily as a result of increased sales.
The foregoing summary is qualified in its entirety by reference to the complete text of the Third
Amendment to the LSA, a copy of which is attached as Exhibit 10.1 hereto.
Item 9.01 Financial Statements and Exhibits.
(c) Exhibits. The following are furnished as exhibits to this Current Report:
|
|
|
Exhibit No. |
|
Description of Exhibit |
|
|
|
10.1
|
|
Third Amendment to the Amended and Restated Loan and Security Agreement |
2